Who is sponsoring NCT04021316?

NCT04021316 is sponsored by Imperial College London.

What condition does NCT04021316 study?

NCT04021316 studies Venous Ulcer, Allograft.

Is NCT04021316 still recruiting?

NCT04021316 is currently terminated. Last updated 28 September 2023.

Last reviewed 2023-09-28 · How we verify

NCT04021316: DAVE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Decellularised Dermis Allograft for the Treatment of Chronic Venous Leg Ulceration

Terminated NA Last updated 28 September 2023

What this trial tests

NA trial testing dCELL® Human Dermis (decellularised dermal skin allograft - DCD) in Venous Ulcer in 71 participants. Terminated before completion.

Timeline

1 October 2019

Primary endpoint
10 April 2023

10 April 2023

Quick facts

Lead sponsor	Imperial College London
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	71
Start date	1 October 2019
Primary completion	10 April 2023
Estimated completion	10 April 2023
Sites	17 locations across United Kingdom

Drugs / interventions tested

dCELL® Human Dermis (decellularised dermal skin allograft - DCD)
Compression bandaging therapy

Conditions studied

Venous Ulcer — all drugs for Venous Ulcer →
Allograft — all drugs for Allograft →

Sponsor

Imperial College London

Who can join

18 and older, any sex, with Venous Ulcer or Allograft. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Does the use of decellularised dermis allograft in addition to compression therapy promote healing in chronic venous leg ulceration compared to compression therapy alone

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Venous Ulcer

Currently open trials in the same condition.

NCT06031714 — Fetal Cell Receptors Repertoire · NA · recruiting
NCT05805137 — Monitoring of Venous Ulcers Using a Bioimpedance Measurement Based Method and System · NA · recruiting

Other Imperial College London trials

Trials by the same sponsor.

NCT06035861 — Endothelial Cell Activation and Total Pulmonary Resistance in PAH · NA · not yet recruiting
NCT07397455 — Development of a Controlled Human Infection Model for Assessment of SARS-CoV-2 Omicron Subvariants · Phase 1 · not yet recruiting
NCT07422532 — A Multi-centre Trial to Assess the Efficacy and Safety of the Omnipod 5 System in People With Type 2 Diabetes Undergoing · NA · not yet recruiting
NCT07389031 — Maralixibat for Intrahepatic Cholestasis of Pregnancy · Phase 2 · not yet recruiting
NCT07358897 — Gender Affirming Hormone Therapy and Immune Function in Trans Individuals - The GIFT Study · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04021316 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Imperial College London
Last refreshed: 28 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04021316.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing